Title |
Carbapenem-Resistant Enterobacter cloacae in Patients from the US Veterans Health Administration, 2006–2015
|
---|---|
Published in |
Emerging Infectious Diseases, May 2017
|
DOI | 10.3201/eid2305.162034 |
Pubmed ID | |
Authors |
Brigid M. Wilson, Nadim G. El Chakhtoura, Sachin Patel, Elie Saade, Curtis J. Donskey, Robert A. Bonomo, Federico Perez |
Abstract |
We analyzed carbapenem-resistant Enterobacteriaceae (CRE) trends among patients from the US Veterans Health Administration (VHA). After the emergence of CRE in the eastern United States, resistance rates remained stable in Klebsiella pneumoniae but increased in Enterobacter cloacae complex, suggesting a "second epidemic". VHA offers a vantage point for monitoring nationwide CRE trends. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 44% |
Australia | 1 | 11% |
Unknown | 4 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 78% |
Practitioners (doctors, other healthcare professionals) | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 50 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 20% |
Student > Ph. D. Student | 6 | 12% |
Student > Bachelor | 4 | 8% |
Other | 3 | 6% |
Professor | 2 | 4% |
Other | 10 | 20% |
Unknown | 15 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 18% |
Biochemistry, Genetics and Molecular Biology | 6 | 12% |
Agricultural and Biological Sciences | 5 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
Immunology and Microbiology | 3 | 6% |
Other | 6 | 12% |
Unknown | 18 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2023.
All research outputs
#1,505,268
of 23,978,283 outputs
Outputs from Emerging Infectious Diseases
#1,691
of 9,336 outputs
Outputs of similar age
#30,162
of 313,529 outputs
Outputs of similar age from Emerging Infectious Diseases
#33
of 118 outputs
Altmetric has tracked 23,978,283 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,336 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 44.3. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,529 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.